Cited by 20Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease PreventionAtherosclerosis and Cardiovascular Diseases

Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia

Alef, Matthew J., Tzeng, Edith, Zuckerbraun, Brian S.·2012·Nitric Oxide

Abstract

Vascular intimal hyperplasia (IH) limits the long term efficacy of current surgical and percutaneous therapies for atherosclerotic disease. There are extensive changes in gene expression and cell signaling in response to vascular therapies, including changes in nitric oxide (NO) signaling. NO is well recognized for its vasoregulatory properties and has been investigated as a therapeutic treatment for its vasoprotective abilities. The circulating molecules nitrite (NO(2)(-)) and nitrate (NO(3)(-)), once thought to be stable products of NO metabolism, are now recognized as important circulating reservoirs of NO and represent a complementary source of NO in contrast to the classic L-arginine-NO-synthase pathway. Here we review the background of IH, its relationship with the NO and nitrite/nitrate pathways, and current and future therapeutic opportunities for these molecules.

Integrity signals

Registry

Crossref · 10.1016/j.niox.2012.03.014

Cites

166 of 166 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dietary nitrate and nitrite confer protection from intimal hyperplasia in rodents.

    “Further, dietary nitrate and nitrite confer protection from intimal hyperplasia in rodents[117–119]”
  • Multiple preclinical studies suggest nitrite may be effective for prevention and/or treatment of many cardiovascular disorders or risk factors for cardiovascular disease including peripheral artery disease, atherosclerosis, chronic heart failure, stroke, diabetes, and hypertension.

    “multiple studies in preclinical models suggest that nitrite also may be effective for the prevention and/or treatment of many cardiovascular disorders or risk factors for CVD including peripheral artery disease (4, 69, 146), atherosclerosis (2, 3, 5, 127), chronic heart failure (32, 122), stroke (50, 82, 150), diabetes (138), and hypertension (22, 57, 58, 128).”

Cites

Flagged first, then by citations

1 of the 167 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Alef, M. J., Tzeng, E., & Zuckerbraun, B. S.
Affiliations
University of Pittsburgh (US)
Corresponding author
Zuckerbraun, Brian S.
Venue
Nitric Oxide
Publisher
Elsevier BV
Published
2012-05
Volume
26
Issue
4
Pages
285-294
ISSN
1089-8603 (ISSN-L)
OpenAlex
W2026972928
Cited by
20
References
167
Citations by year
2025: 1 · 2022: 1 · 2020: 1 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
0.31
Type
journal article
Language
en
Open access
closed
Locations
  • Nitric Oxide (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Department of Veterans Affairs (I01 BX000635)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
intimal hyperplasia, nitrite, nitrate, no-signaling, atherosclerosis, vascular protection, therapeutic target
MeSH terms
Animals, Humans, Hyperplasia, Nitrates, Nitric Oxide, Nitrites, Vascular Diseases, Xanthine Dehydrogenase, Signal Transduction, Tunica Intima

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review